Results

Total Results: 2,505 records

Showing results for "diseases".

421. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/case-management_research-protocol.pdf
     June 06, 2011 - Some systematic reviews have assessed case management for individual chronic diseases, including a … Patient health outcomes (include but are not limited to): overall quality of care; disease- specific … quality of care; disease-specific health outcomes; quality of life; patient satisfaction with care … The effectiveness of disease and case management for people with diabetes: a systematic review. … Quality of care, as indicated by disease-specific process measures, receipt of recommended health care

422. Disposition of Comments Report for Local Therapies for Unresectable Primary Hepatocellular Carcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_disposition-comments.pdf
     May 24, 2013 - This is because patients with different disease characteristics are candidates for different treatments … patients with small accessible tumors are candidates for ablation whereas more extensive disease would … If they have more advanced disease (intermediate-staged HCC) with multifocal tumors or large tumors … Ablative therapies are limited to patients with very to early stage disease and are never used for … TEA(TAE) are both patients with multifocal disease.

423. Nephropathy-Contrast-Induced Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_research-protocol.pdf
     October 01, 2013 - (CKD), end stage renal disease (ESRD), mortality, and other adverse events? … Preliminary Search Strategies PubMed Search: ("Kidney diseases"[mh] OR "Kidney disease"[tiab] OR " … kidney diseases"[tiab] OR Nephropathy[tiab] OR "acute kidney injury"[tiab] OR "renal disease"[tiab]) … ' OR 'kidney diseases' OR nephropathy OR 'acute kidney injury' OR 'renal disease' Cochrane search: … #1 MeSH descriptor: [Kidney Diseases] explode all trees #2 "kidney disease":ti,ab,kw (Word variations

424. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0404_01-14-2011.pdf
     January 01, 2011 - )  PAH is a progressive and incurable disease with a variety of etiologies and a pathology that … Based on disease etiology and severity of the disease, the timing and optimal combinations of drug therapy

425. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
     September 01, 2011 - amount and quality of the information available regarding treatment of JIA compared to other chronic diseases … Reviewer #2 Introduction (Pg 19, line 54) RF-poly and RF+poly - these really are two different diseases … The sub-types of JIA/JRA/JCA are all quite different diseases in terms of presentation, response, outcome … Juvenile idiopathic arthritis is not a disease. … The potential role of disease registries has been added.

426. Santa_ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/santa_eccs2012.pdf
     February 01, 2013 - Slide 7: Comparison of Heart Disease Screening  Tests  (1 of 2) • Began  with the grades used … Preventive Services Task  Force. • Built ratings of common coronary or vascular disease screening … tests. • Added new evidence, frequency/burden  of disease, cost, and application to other  diseases … rated  tests  underused   o Poorly  rated  tests  overused Slide 8: Comparison of Heart Disease … • These people significantly overestimated their risk for cardiovascular disease.

427. Renal-Function Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_executive.pdf
     August 01, 2014 - ; CHD = coronary heart disease; CKD = chronic kidney disease; ESRD = end-stage renal disease; KQ = Key … National Institute of Diabetes and Digestive and Kidney Diseases, Division of Kidney, Urologic, and Hematologic … Diseases. … Plasma elimination of cardiac troponin I in end-stage renal disease. … Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American

428. Disposition of Comments for Pulmonary Arterial Hypertension: Screening, Management, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_disposition-comments.pdf
     April 25, 2013 - Response TEP Member 7 Executive Summary ES-1: The WHO classification of pulmonary hypertensive diseases … Patients with connective tissue diseases, primarily scleroderma, represent the largest subset of patients … Patients with connective tissue diseases, primarily scleroderma, represent the largest subset of patients … PAH are 4 distinct diseases with different presentations, pathobiology, response to therapy, and natural … extremely relevant to the SSc population of patients, and potentially to other connective tissue diseases

429. Disposition of Comments for CER 211: Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
     December 20, 2018 - activity” – not exactly improved disease activity, improved disease control? … discovering, developing, and delivering innovative, transformational medicines for patients with serious diseases … Since we know that autoimmune diseases evolve as a continuum starting years before the first clinical … is treatment- naïve disease. … Reductions in disease activity in the AMPLE trial: clinical response by baseline disease duration.

430. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Potential High-Impact Interventions Report Priority Area 04: Dementia (Including Alzheimer’s Disease … Scanning System Potential High- Impact Interventions: Priority Area 04: Dementia (Including Alzheimer’s Disease … Priority Area 04: Dementia (Including Alzheimer’s Disease) Topic High-Impact Potential 1. … Off-label intranasal insulin for treatment of Alzheimer’s disease No high-impact potential; archived … that treatments that safely increase insulin levels or insulin signaling efficiency might improve disease

431. Renal-Cancer Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
     April 20, 2015 - Diagnostic Evaluation and Detection of Disease All solid renal masses and cystic lesions with solid … Patients with surgical chronic kidney disease (defined as chronic kidney disease as a result of surgical … resulting from medical renal disease. … syndromes and predictors of advanced/metastatic disease (e.g. … Mullins, J.K., et al., Tumor complexity predicts malignant disease for small renal masses.

432. Colorectal-Cancer-Protocol_130520 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
     May 20, 2013 - For stage I, II, and III disease, surgical resection is the primary treatment. … Approximately 20% to 30% of patients develop recurrent disease. … Disease characteristics (e.g., tumor grade) iii. … Disease characteristics (e.g., tumor grade) iii. … colorectal cancer” as an inclusion criterion, colon cancer and rectal cancer are somewhat different diseases

433. Protocol Amendment - Safety of Vaccines 030413 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccines-safety-protocol-130325.pdf
     September 18, 2012 - their role in eradicating smallpox and controlling polio, measles, rubella, and other infectious diseases … pregnant women.5 Increasing vaccination rates remains critically important, as vaccine-preventable diseases … Centers for Disease Control and Prevention. … Centers for Disease Control and Prevention. … Centers for Disease Control and Prevention.

434. Postpartum Care for Women Up to One Year After Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
     April 25, 2022 - year after giving birth (except interpregnancy interval, unintended pregnancies, and chronic diseases … to 1 year after giving birth (except interpregnancy interval, unintended pregnancies, and chronic diseases … to 1 year after giving birth (except interpregnancy interval, unintended pregnancies, and chronic diseases … Centers for Disease Control and Prevention National Center for Health Statistics. … Atlanta, Georgia: Centers for Disease Control and Prevention, U.S.

435. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 13: Pulmonary Disease … Healthcare Horizon Scanning System Potential High- Impact Interventions: Priority Area 13: Pulmonary Disease … ES-2 Pulmonary Disease, Including Asthma, Interventions ........................................... … Priority Area 13: Pulmonary Disease, Including Asthma Topic High-Impact Potential 1. * Ivacaftor … The experts deemed one topic as having potential for high impact—a new disease-modifying drug targeted

436. S16 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s16.pdf
     October 01, 2007 - Research using cohort and case-control designs, disease and intervention registries, and outcomes studies … Adherence to therapies Disease stage and severity Risk of complications or side-effects of therapy … Trials; registries25 Adherence high in RCTs and community patients with heart disease (�80%); little … CEA indicates carotid endarterectomy; CVD, cardiovascular disease. … A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

437. High-Cholestorol-Medicines-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
     February 01, 2014 - valve disease, congenital heart disease, and hypertension. … (CHD), cerebrovascular disease, and peripheral artery disease. … CHD = coronary heart disease; FDA = U.S. … without preexisting cardiovascular disease. … Reduced or modified dietary fat for preventing cardiovascular disease.

438. Methods Guide for Medical Test Reviews Chapter 10 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-decision-models_methods.pdf
     July 01, 2012 - head-to-head; and explore hypothetical scenarios (e.g., assume hypothetical interventions for incurable diseases … In brief, the report focuses on the diagnosis of the disease (AD) in the three scenarios of patients … Simplified analytic framework AD = Alzheimer’s disease; AChE-I = acetylcholinesterase inhibitors … Management options for mild cognitive impairment AD = Alzheimer’s disease; MCI = mild cognitive … The MISCAN simulation program for the evaluation of screening for disease.

439. Outcome Definition and Measurement in Observational Comparative Effectiveness Research
     effectivehealthcare.ahrq.gov/sites/default/files/outcome-definition-and-measurement-chapter-6.pptx
     January 01, 2013 - Temporal Aspects The nature of the disease state to be treated, the mechanism, and the intended effect … ), or recurrent (new occurrence or exacerbation of disease in a patient who has a previous diagnosis … The disease of interest may be chronic (a long-term or permanent condition), acute (a condition with … Disease-Specific or Population-Specific Questionnaires While a questionnaire can be disease-specific … These measures include assessments of multiple related outcomes within a disease area.

440. Microsoft Word - finapps.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes-2007.pdf
     January 01, 2007 - Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors … Progression of atherosclerotic renovascular disease: A prospective population-based study. … Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting … stage 3A, baseline GFR 41-59 mL/min 2 Chronic kidney disease stage 3A, baseline GFR 30-40 mL/min 3 … ARAS, atherosclerotic renal artery stenosis; CKD, chronic kidney disease; CVD, cardiovascular disease